Use of NMN for the prevention and/or treatment of joint pain induced by physical activity, and corresponding compositions

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11730752
APP PUB NO 20230060438A1
SERIAL NO

17791092

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to nicotinamide mononucleotide, a pharmaceutically acceptable derivative thereof, or a pharmaceutically acceptable salt thereof, for use in preventing and/or treating joint pain induced by physical activity, and compositions comprising same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • NUVAMID SA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bermond, Guillaume Marseilles, FR 18 0
Garcon, Laurent Sausset les Pins, FR 9 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 22, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 22, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 22, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00